This Case CCC Cytometry &Imaging Microscopy Core provides access to instrumentation, instrumentation specific training, experimental consultation, data analysis, and data analysis training. By special request, the Core provides technical services preliminary to measurement such as cell culture, fixation, staining, etc. The Core covers flow cytometry, laser scanning cytometry, imaging flow cytometry, fluorescence-activated cell sorting (FACS), automated live-dead cell counting, confocal laser scanning microscopy, fluorescence video microscopy, and bright field automated whole slide imaging and has up-to-date analytical software for each activity. These services are broad-based, providing fundamental tools for basic sciences. The Core has two sites on the CWRU campus and another site through an alliance with the Case Center for AIDS Research (CFAR). The services are: 1) user access to instruments, 2) staff assisted use of instruments, and 3) performed by staff. The user base consists largely of Case CCC members from all the Research Programs with members from the Hematopoietic Disorders, Developmental Therapeutics, and Cancer Imaging Programs being the heaviest users. Overall, this Core provides fundamental services that may or may not be a large part of any one particular paper or grant but support the research efforts of a well-funded and highly published group of investigators. Services such as cell counting, cell sorting, or simple immunofluorescence analysis may or may not make it into a publication even though they are used on a daily basis to maintain cell lines, quality control cells, or to provide analysis that impacts the direction of research represented by publications and grants. The Core has been critical in studies that: provided a mechanism-based rationale for the development of HDAC and HAUSP inhibitors for combined use in cancer therapy;elucidated the mechanisms that initiate and maintain OIS in epithelial cells;and determining the inhibitory role for KLF4 during breast cancer metastasis.

Public Health Relevance

The Case Comprehensive Cancer Center is Northeast Ohio's only NCI designated comprehensive cancer center providing bench-to-bedside medical research involving partnerships between basic, clinical and population scientists to speed translation of laboratory discoveries into new prevention/intervention and cancer treatments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-24
Application #
8765388
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
24
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Belur Nagaraj, Anil; Kovalenko, Olga; Avelar, Rita et al. (2018) Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer. Clin Cancer Res 24:4588-4601
Yang, Xiaosong; Pan, You; Qiu, Zhaojun et al. (2018) RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells. Clin Cancer Res 24:1629-1643
Liu, Xia; Taftaf, Rokana; Kawaguchi, Madoka et al. (2018) Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. Cancer Discov :
Belur Nagaraj, Anil; Joseph, Peronne; Kovalenko, Olga et al. (2018) Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. Gynecol Oncol 151:525-532
Li, Jiayang; Gresham, Kenneth S; Mamidi, Ranganath et al. (2018) Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy. Int J Cardiol 273:168-176
Enane, Francis O; Saunthararajah, Yogen; Korc, Murray (2018) Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells. Cell Death Dis 9:912
Lennon, Donald; Solchaga, Luis A; Somoza, Rodrigo A et al. (2018) Human and Rat Bone Marrow-Derived Mesenchymal Stem Cells Differ in Their Response to Fibroblast Growth Factor and Platelet-Derived Growth Factor. Tissue Eng Part A 24:1831-1843
Evans, Daniel R; Venkitachalam, Srividya; Revoredo, Leslie et al. (2018) Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer. Hum Mutat 39:1092-1101
Augestad, Knut M; Keller, Deborah S; Bakaki, Paul M et al. (2018) The impact of rectal cancer tumor height on recurrence rates and metastatic location: A competing risk analysis of a national database. Cancer Epidemiol 53:56-64
Chen, Lechuang; Feng, Zhimin; Yue, Hong et al. (2018) Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun 9:4585

Showing the most recent 10 out of 1227 publications